Swiss drugmaker Novartis AG has not ruled out sticking with its 77 percent stake in US-listed eyecare group Alcon, Novartis chief executive Joe Jimenez was quoted as saying on Tuesday. “The intention is to have 100 per cent. But Nestle owned 77 per c…
Category: Business
pSivida Corp. to Present at the Maxim Group Growth Conference
WATERTOWN, Mass.–(BUSINESS WIRE)–pSivida to present at Maxim Group Growth Conference
Santen Inc. Appoints Associate Director of Strategic Marketing
Santen Inc., a wholly owned subsidiary of Santen Pharmaceuticals, has announced the appointment of Yuan Chang as the Associate Director of Strategic Marketing. Full Story →
RXi Pharmaceuticals Reports Financial Results for the Third Quarter of 2010
WORCESTER, Mass.–(BUSINESS WIRE)–RXi Pharmaceuticals Corporation (Nasdaq: RXII) today reported its financial results for the third quarter ended September 30, 2010. RXi Pharmaceuticals is a recognized leader in RNAi-based therapeutic discovery and development with a comprehensive therapeutic platform that includes both…
Ophthalmic Imaging Systems Reports Third Quarter Financial Results
Ophthalmic Imaging Systems, a leading digital imaging, image management, Electronic Medical Records (EMR) and Practice Management (PM) company, today reported financial results for the three and nine months ended September 30, 2010, and provided an u…
Carl Zeiss Meditec Receives FDA Clearance for the IOLMaster 500 Biometer
Carl Zeiss Meditec today announced that the IOLMaster 500, the newest biometer used to calculate all necessary eye measurements for optimal lens selection for cataract surgery procedures, has received marketing clearance from the U.S. Food and Drug A…
IRIDEX Reports Improved Third Quarter 2010 Financial Results
IRIDEX Corporation today reported financial results for the third quarter ended October 2, 2010. Earnings of $0.9 million or $0.09 per diluted share, up from $0.6 million or $0.07 per diluted share reported in the third quarter 2009. Total sales incr…
Bausch + Lomb Surgical Strengthens Management Team with Three New Appointments
Bausch + Lomb, the global eye health company, has appointed three industry veterans to key management roles in its Surgical business. Brad Paddock has been hired as vice president, Sales; Anthony Sine is appointed vice president, Business Development…
pSivida Corp. Reports Results for the First Quarter Ended September 30, 2010
WATERTOWN, Mass.–(BUSINESS WIRE)–pSivida reports first quarter fiscal 2011 results
InSite Vision Reports Third Quarter 2010 Financial Results
ALAMEDA, Calif.–(BUSINESS WIRE)–InSite Vision Incorporated (OTCBB:INSV) today reported operating and financial results for the quarter ended September 30, 2010. Total revenue for the third quarter of 2010 was $3.2 million with an operating income of …
InSite Vision Awarded Therapeutic Discovery Project Grant for ISV-502 and ISV-303 Clinical Development
ALAMEDA, Calif.–(BUSINESS WIRE)–InSite Vision Incorporated (OTCBB: INSV), a company developing novel ophthalmic therapeutics, today announced that it will receive $489,000 under the U.S. Government’s Qualifying Therapeutic Discovery Project (“QTDP”) …
Freedom Meditech Fills Executive Team
Freedom Meditech, Inc., the developer of non-invasive, ophthalmic-based products to detect and manage diabetes, today announced the appointment of Keith D. Ignotz as President & Chief Operating Officer and John F. Burd, Ph.D. as Chief Science Off…
pSivida Corp Awarded Two Therapeutic Discovery Project Grants Totaling $489,000
WATERTOWN, Mass.–(BUSINESS WIRE)–pSivida receives two Therapeutic Discovery Project Grants totaling $489,000 for drug delivery technologies
STAAR Surgical third quarter total net sales increases 6% to $13.2 million
STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today reported results for the third quarter ended October 1, 2010. Revenue for the period grew 6% to $13.2 million reflecting core produ…
Akorn Reports Third Quarter 2010 Results
LAKE FOREST, Ill.–(BUSINESS WIRE)–Akorn, Inc. (NASDAQ: AKRX), a niche generic pharmaceutical company, today reported financial results for the third quarter ended September 30, 2010. Consolidated revenue for the third quarter of 2010 was $21.7 millio…
Allergan third quarter diluted loss per share increases to $2.21
Allergan, Inc. today announced operating results for the quarter ended September 30, 2010. Allergan also announced that its Board of Directors has declared a third quarter dividend of $0.05 per share, payable on December 1, 2010 to stockholders of reco…
Novartis Wins Challenge Against J&J Over Its French Contact Lens Patent
Novartis AG won an appeals court bid in Paris to uphold the French portion of its European patent for extended-wear lenses, defeating claims by Johnson & Johnson to overturn the intellectual-property protection. The ruling by Frances Court of App…
pSivida Corp Announces First Quarter 2011 Financial Results Release Date and Conference Call Information
WATERTOWN, Mass.–(BUSINESS WIRE)–pSivida announces first quarter 2011 financial results release date and conference call information
Ziemer Group Announces Product Upgrades
Ziemer Group (Port, Switzerland) unveiled its Femto LDV Crystal Line and launched its Dual Scheimpflug Camera System at the AAO Annual Meeting.The Femto LDV Crystal Line, known as Z-LASIK Crystal Plus, has a pulse rate of more than 5 MHz. According t…
InSite Vision to Report Third Quarter Financial Results on November 4, 2010
ALAMEDA, Calif.–(BUSINESS WIRE)–InSite Vision Incorporated (OTCBB: INSV) announced today that it will report financial results for the third quarter ended September 30, 2010 on Thursday, November 4, 2010. Company management will also host a conferenc…